KLOW 80mg Blend for Research

What the KLOW 80mg blend contains, how blends are documented, and what researchers should confirm about composition.

KLOW 80mg Blend for Research

The price for KLOW Peptide Blend 80mg is $169.99 at , a trusted Australian supplier. on orders . View the catalogue here. Research Use Only.

Buy KLOW in Australia · view product options

KLOW Peptide Blend 80mg (KLOW Peptide Blend)

Check current availability and choose options on the product page. Research Use Only.

It combines GHK-Cu, BPC-157, TB-500 and KPV in one vial; 80mg is the total labelled blend amount. View KLOW 80mg for current availability, dispatch information and the linked batch report.

In stock · Australian dispatch; check the current dispatch estimate.

Identity and component amounts reported; peptide purity not reported. Batch JUNE-2026-198546 · tested 2026-07-27 .

KLOW is a blend name, not a molecule

KLOW is a combination of four separate research peptides: GHK-Cu, TB-500, BPC-157 and KPV. That matters commercially, because a blend cannot be compared to a single-compound vial on price per milligram without first establishing what is actually inside it. Two vials sold under the same four-letter name can hold quite different ratios.

The released batch states the split explicitly. Batch JUNE-2026-198546 reports GHK-Cu 66.97mg; TB-500 11.41mg; BPC-157 11.23mg; KPV 10.35mg .

Those four figures total more than the 80mg headline. The pack size describes the combined labelled peptide content; the batch report describes what the laboratory measured in the sample. Always price a blend against the batch report, not the product name.

What the KLOW batch report measures

The linked Janoshik report for batch JUNE-2026-198546 records component identity and measured amounts. It does not report peptide purity. An identity-and-amount result should not be presented as a purity percentage.

When comparing another KLOW listing, check exactly which analyses its report includes, which components were measured and whether the report matches the offered batch. A percentage alone does not identify the test method or what was measured.

The honest comparison is against the four components bought individually, at the strengths the batch report actually shows, rather than against a single-compound vial of similar headline weight. lists GHK-Cu , TB-500 , BPC-157 and KPV as separate lines, so the arithmetic is available on the site.

Separate vials and a premixed blend have different contents and documentation. Review the report linked to each exact listing. A report for one ingredient does not establish the purity or composition of the finished KLOW blend.

What a blend format does and does not simplify

The practical argument for a blend is fewer vials, one batch report to file, and one item to store and track. The practical argument against it is that the ratio is fixed at the point of manufacture. Four separate vials can be documented, stored and drawn on independently; a blend cannot be separated back into its components once combined.

For record-keeping, retain the vial label, batch identifier and matching report. For KLOW, record the reported amount of each component and the limits of the analyses performed. For separate vials, retain each product’s own batch documentation.

What the research literature covers

Published studies of the individual ingredients do not establish the behaviour of ’s finished KLOW blend. Its batch report describes analytical findings for the submitted sample, not a demonstrated biological effect of the combination.

The KLOW identity and component review sets out what each component’s literature does and does not establish, and where the evidence stops.

Evidence note: this article describes procurement facts and research literature only. It is not a recommendation, a protocol, or evidence of safety or efficacy in humans.

Check the KLOW 80mg product page for the current price, availability, dispatch estimate and matching batch report before ordering. Stock and dispatch information can change. Research Use Only.

KLOW and each of its component peptides are supplied for research and educational purposes only. None is listed on the Australian Register of Therapeutic Goods (ARTG), and none must be consumed by humans or animals. All experimental use should follow institutional safety guidelines and relevant regulations.

Pricing a blend against its parts? View KLOW in Australia . For related research, see the KLOW identity and component review and the KPV research overview .

This compound is supplied for in vitro laboratory and educational research only. It is not listed on the Australian Register of Therapeutic Goods (ARTG) and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Not for human or animal consumption, therapeutic use, or diagnostic procedures. By purchasing, you confirm you are a qualified researcher or acting on behalf of a licensed research facility, and you assume full responsibility for the safe handling, storage, and lawful use of this compound.

Research Use Only. This article is for general laboratory research information and makes no therapeutic claim.
Keep reading

More from the journal